Trial Profile
Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and Efficacy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2020
Price :
$35
*
At a glance
- Drugs Rosuvastatin/telmisartan (Primary)
- Indications Dyslipidaemias; Hypertension
- Focus Adverse reactions
- Sponsors Ildong Pharmaceutical
- 23 Nov 2018 New trial record